Home > Insider Trading > Filing (0001209191-22-049065)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
850261	Sorrento Therapeutics Inc.	SRNE	Biological Products, (No Disgnostic Substances) (2836)	330344842

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1470981	Henry Ji	C/O Sorrento Therapeutics, Inc. 4955 Directors Place San Diego CA 92121	See Remarks	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-09-07	88,888	$2.02	4,765,805	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Call Option (right to buy)	Acquisiton	2022-09-07	759	$40.66	75,900	$12.00
Common Stock	Call Option (right to buy)	Acquisiton	2022-09-07	129	$41.66	12,900	$12.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
759	2022-09-07	2024-01-19	No	4	P	Indirect
129	2022-09-07	2024-01-19	No	4	P	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,271,693	Indirect	See Footnote
Common Stock	40,000	Indirect	By spouse

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.01 to $2.02, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.
Shares are held in family trusts of which the Reporting Person is a co-trustee with his spouse.